Femiglandin GLK + E

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.007724.07.15
Date of registration and renewal:20.07.2015
Dosage form: & nbspCapsules weighing 695 mg.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp BAA sources of antioxidant substances and substances that affect energy metabolism BAA to reduce the risk of functional disorders of female cyclic processes
Composition: & nbspIngredients: cold pressed primrose oil, alpha-tocopherol acetate, E422, E1440, E407, E339.
Scope: & nbspDFor realization to the population as a biologically active additive to food - a source of linoleic and gamma-linolenic acids, an additional source of vitamin E.
Suggested Usage: & nbspAT2 capsules 2 times a day with meals. Duration of admission is 1 month. If necessary, the reception can be repeated
Contraindications:ANDindividual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in a dry place, protected from direct sunlight and out of reach of children, at a temperature of no higher than 25 ° C.
Research protocols:ATreplacing the certificate of state registration No. RU.77.99.11.003.Е.007174.06.15 of 22.06.2015, the expert opinion of the FBUC of the Federal Service for Supervision of Consumer Rights Protection of the Russian Federation No. 10-2FTS / 2035 of May 21, 2015,
Recipient:Hankintatukku Arno Latvus OyHankintatukku Arno Latvus Oy Finland
Information update date: & nbsp10.04.2016
Instructions
Up